Insys Therapeutics, Maker of Subsys, Files Chapter 11

Phoenix-based opioid manufacturer Insys Therapeutics has officially filed for Chapter 11 bankruptcy protection just five days after agreeing to pay $225 million to settle the litigation against it concerning the powerful fentanyl spray, Subsys.  Insys asked the court to “allow it to sell its assets to pay more than $250 million in debts,” according to